Objective: To investigate the serum concentration of folic acid, procalcitonin (PCT), C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) as biomarkers in the differentiation of the severity of ulcerative colitis (UC).
Introduction
Ulcerative colitis (UC) is a type of nonspecific intestinal inflammation with unknown etiology [1] [2] [3] and complex pathogenesis. Inflammation, as the initiating factor, plays an extremely important role in its occurrence, development and prognosis for patients [4, 5] . The primary symptom of active disease is abdominal pain and diarrhea mixed with blood [1, 6] . Additional symptoms include weight loss, fever and anemia which occur as the disease progresses. The exact pathogeny of UC is unknown. Published studies implicate immune system dysfunction, heredity, changes in the normal gut bacteria and environmental factors as being involved in the pathogenesis of UC [4, 7, 8] . Generally, the diagnosis and assessment of disease activity is performed using clinical endoscopic, histological and radiological investigations which then informs what the appropriate treatment plan is for the patient. However, assessment of acute disease activity is difficult because diagnosis depends on several subjective components.
Studies have shown that deficiency of folic acid, also known as vitamin B9, can cause a series of diseases such as glossitis, diarrhea, depression, confusion, anemia and inflammatory bowel disease [9, 10] . Previous studies have also shown that folic acid deficiency is an important factor for UC development. Procalcitonin (PCT) is a peptide precursor of the hormone calcitonin, the latter being involved in calcium homeostasis. Several studies have demonstrated that serum concentration of PCT influence the immunologic responses that contribute to systemic inflammatory responses and septic shock [11] [12] [13] . Many investigations have demonstrated that serum PCT is a promising biomarker of bacterial infection in patients with sepsis and its related conditions [14] [15] [16] [17] . The correlation between serum PCT levels and UC activity is not fully understood. In our present work, we performed a prospective study to analyze the efficacy of serum folic acid, PCT, CRP and ESR as biomarkers in the evaluation of UC activity.
Material and Methods

Study subjects
Fifty one patients with confirmed diagnosis of UC were recruited from January 2014 to August 2017 in the Department of Gastroenterology of North China Petroleum Administration Bureau General Hospital. Of the included 51 UC patients, 22 had severe diseases and other 29 had mild/moderate disease according to Truelove-Witts classification criteria [18] (Figure 1) . Our study also included 26 healthy subjects. The study design was reviewed and approved by the ethics committee of the North China Petroleum Administration Bureau General Hospital Review Board and the Clinical Study Committee. Written informed consent was obtained from all of the subjects included in the study. The diagnosis of UC was confirmed by a typical history combined with appropriate endoscopic, histopathological and radiologic findings. Patients with colorectal cancer and other malignant diseases, megacolon or concomitant diseases, obvious infection or sepsis, liver disorder and renal diseases were excluded.
Serum folic acid, PCT, CRP and ESR detection
Peripheral venous blood was extracted from all of the included subjects for the examination of folic acid, PCT, CRP and ESR. Serum PCT was detected by immunochemiluminescence assay (LUMAT LB9507, purchased from BRAHMS co. Ltd.). Serum folic acid was examined by electrochemical method assay and serum CRP was detected using an immunoscattering turbidimetry assay (DADE BEHRING BN II, purchased from Dade Behring co. Ltd.). ESR was examined by automatic erythrocyte sedimentation analyzer (ALIFAX Test 1, purchased from ALIFAX co. Ltd).
Statistical analysis
All the data was analyzed by STATA11.0 statistical software (http://www.stata.com) and the measurement data was expressed by s x ± and the comparison was made by one-way ANOVA and student-t test. The enumeration data were expressed with a relative number (n,%), and the comparison was mad by chi-square test or fisher's exact test. The correlation between serum PCT, CRP and ESR was analyzed by Pearson correlation test. Regarding the diagnosis test, sensitivity, specificity, and the area under the ROC curve (AUC) were calculated according to the Bayes' theorem. Two tails p<0.05 meant a statistical difference.
Results
General characteristics
The general characteristics of included subjects were demonstrated in Table 1 . There was no statistical difference between the control, mild/moderate and severe groups in terms of age, gender, height, course and previous treatment drugs. The proportion of patients with extensive disease in the severe group was significantly higher than that of the mild/moderate group (p=0.002). The body weight of the control group was significantly higher than the UC group (p<0.001). However, the difference was not significant between the mild/moderate and severe groups (p=0.35).
Serum folic acid, PCT, CRP and ESR comparison
The distribution of serum PCT, CRP and ESR is illustrated in Figure 2 . The serum PCT, CRP and ESR in the control group were significantly lower than those of the mild/ moderate and severe UC groups (p<0.001). However, the Figure 3 ).
Correlation between serum CRP, ESR and PCT
The correlation between serum CRP, ESR and PCT were examined by a Pearson correlation test and line regression analysis. However, there was no correlation between each of them, except for folic acid and ESR (r=-0.334, p=0.017), ( Figure 4 ). 
Discussion
In the present work, we prospectively analyzed the serum folic acid, PCT, CRP and ESR as biomarkers in the differentiation of ulcerative colitis activity. The results demonstrate that the serum PCT, CRP and ESR in UC patients were significantly higher than that of healthy patients. In contrast, serum folic acid was significantly decreased in UC patients compared to healthy controls. Moreover, the serum PCT, CRP and ESR were significantly elevated in severe disease compared to mild/moderated UC and serum folic acid was significantly decreased in severe UC patients. In terms of its potential use as biomarkers for UC, serum PCT had good diagnostic accuracy for detecting severe UC compared to serum CRP, folic acid and ESR. Serum PCT was significantly elevated in patients with active UC and could be a promising biomarker for differentiating mild/moderate and severe UC.
PCT, a precursor of calcitonin, is a glycoprotein which is secreted by thyroid follicles. As a non-steroidal antiinflammatory substance, PCT is closely related to the severity of inflammatory reactions and is a serum marker for the diagnosis, differential diagnosis and evaluation of the condition and prognosis of inflammatory reaction [19] [20] [21] [22] . In healthy people, PCT is secreted by parafollicular cells of the thyroid gland and the level of secretion is extremely low, generally below 0.01 mg/mL. When bacterial, fungal and other infections occur, bacterial toxins and inflammatory mediators can stimulate cells (e.g. monocytes and macrophages), organs (e.g. lungs) and tissues outside the thyroid gland to secrete PCT into the blood. Therefore, the level of PCT can reflect the activity of the systemic inflammatory response. Previously, studies have proven that serum PCT is a promising biomarker of bacterial infection in patients with sepsis and its related conditions [13, 17] . The correlation between serum PCT level and UC activity is not fully understood. Koido et al. [23] evaluated the clinical significance of serum PCT in patients with UC. They found that serum PCT levels were significantly correlated with UC activity and it could be used as biomarker for UC activity evaluation. However, Koido et al only included 18 UC cases and 11 healthy controls in their study. The sample size is small with limited statistical power. Moreover, Oruç et al [24] reported that PCT has no diagnostic value in determining disease activity after PCT levels in UC patients failed to show any statistical significance when compared with that of healthy control subjects. Therefore, the clinical usage of serum PCT as biomarker in differentiation UC activity is inconclusive. In this present work, we included 51 UC patients (29 mild/moderate and 22 severe disease), 26 healthy controls and compared the serum folic acid, PCT, CRP and ESR. We found that serum PCT was significantly elevated in patients with active UC which may make it a potentially promising biomarker in thedifferentiation of mild/moderate and severe UC. This conclusion was in accordance with Koido' s results [23] .
Folic acid derivatives participate in the biosynthesis of both purines and pyridines. Formyl folate is required for two of the steps in the biosynthesis of inosine monophosphate, the precursor to GMP and AMP. Folic acid is important for the production and maintenance of new cells, for DNA synthesis and RNA synthesis through methylation and for preventing changes to DNA. Folic acid deficiency hinders DNA synthesis and cell division, affecting hematopoietic cells, neoplasms and inflammatory bowel disease. Deficiency of folic acid was known as an important reason for UC development. Previous publications have demonstrated that levels of serum folic acid decline in UC and other inflammatory bowel disease compared to healthy people [25] [26] . The decrease of serum folic acid in UC patients can be used as serum biomarker for UC diagnosis. However, whether it could be used as a biomarker in the differentiation of ulcerative colitis activity is rarely reported. In our present study, we found that levels of serum folic acid in severe UC patients was significantly lower than that of mild/ moderate UC cases with the differentiation diagnosis sensitivity and specificity of 63.64% (40.66~82.80%) and 65.52% (45.67~82.06%), respectively.
Conclusion
Our findings demonstrate that serum PCT concentration, when compared to folic acid, CRP and ESR were more useful in clinical practice to assess UC activity. However, the sample size was relatively small with limited statistical power, which provides limited clinical evidence. A larger sample size, multicenter prospective clinical studies relevant to evaluation serum folic acid, PCT, CRP, ESR and UC activity are needed to further evaluated its clinical usage and provided more credible clinical evidence.
